14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.94 $4.15 Friday, 3rd May 2024 CLRB stock ended at $3.42. This is 2.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.09% from a day low at $3.34 to a day high of $3.51.
90 days $2.94 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Jul 24, 2020 $1.40 $1.42 $1.36 $1.42 370 592
Jul 23, 2020 $1.48 $1.49 $1.40 $1.41 658 831
Jul 22, 2020 $1.42 $1.62 $1.39 $1.43 3 074 600
Jul 21, 2020 $1.40 $1.42 $1.35 $1.40 1 168 000
Jul 20, 2020 $1.50 $1.52 $1.37 $1.40 716 000
Jul 17, 2020 $1.43 $1.50 $1.41 $1.47 586 100
Jul 16, 2020 $1.38 $1.47 $1.33 $1.45 500 700
Jul 15, 2020 $1.43 $1.46 $1.35 $1.39 389 600
Jul 14, 2020 $1.48 $1.48 $1.35 $1.41 615 400
Jul 13, 2020 $1.50 $1.60 $1.44 $1.46 531 800
Jul 10, 2020 $1.54 $1.57 $1.37 $1.49 810 600
Jul 09, 2020 $1.60 $1.65 $1.51 $1.55 954 500
Jul 08, 2020 $1.51 $1.55 $1.46 $1.53 855 700
Jul 07, 2020 $1.51 $1.51 $1.41 $1.47 583 000
Jul 06, 2020 $1.50 $1.54 $1.44 $1.49 1 095 800
Jul 02, 2020 $1.38 $1.48 $1.38 $1.41 1 087 432
Jul 01, 2020 $1.39 $1.46 $1.34 $1.34 2 226 333
Jun 30, 2020 $1.29 $1.34 $1.27 $1.28 448 173
Jun 29, 2020 $1.31 $1.34 $1.27 $1.30 395 665
Jun 26, 2020 $1.32 $1.33 $1.26 $1.29 648 279
Jun 25, 2020 $1.29 $1.35 $1.29 $1.31 495 791
Jun 24, 2020 $1.29 $1.31 $1.21 $1.28 693 224
Jun 23, 2020 $1.29 $1.38 $1.26 $1.29 1 881 632
Jun 22, 2020 $1.22 $1.24 $1.17 $1.22 523 098
Jun 19, 2020 $1.23 $1.25 $1.21 $1.21 479 101
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT